Arteether is a semi-synthetic artemisinin derivative whose endoperoxide bridge generates reactive radical species lethal to the malaria parasite, used for the treatment of severe and complicated malaria. Simson Pharma's Arteether reference standard and impurities support stability-indicating testing for this critical antimalarial.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Arteether Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.